DaVita Inc. (NYSE:DVA) Shares Acquired by Sei Investments Co.

Sei Investments Co. raised its position in DaVita Inc. (NYSE:DVA) by 212.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 90,769 shares of the company’s stock after purchasing an additional 61,731 shares during the period. Sei Investments Co.’s holdings in DaVita were worth $13,578,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of DVA. SBI Securities Co. Ltd. purchased a new position in shares of DaVita during the fourth quarter valued at approximately $41,000. Quarry LP acquired a new position in DaVita in the 3rd quarter valued at $60,000. Venturi Wealth Management LLC lifted its stake in shares of DaVita by 59.8% during the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock worth $61,000 after purchasing an additional 152 shares during the period. Versant Capital Management Inc boosted its holdings in shares of DaVita by 58.7% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $68,000 after purchasing an additional 169 shares during the last quarter. Finally, Blue Trust Inc. grew its position in shares of DaVita by 39.7% in the fourth quarter. Blue Trust Inc. now owns 461 shares of the company’s stock valued at $76,000 after purchasing an additional 131 shares during the period. 90.12% of the stock is owned by institutional investors and hedge funds.

DaVita Stock Performance

NYSE:DVA opened at $150.29 on Friday. The firm has a 50-day moving average of $157.39 and a two-hundred day moving average of $157.50. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21. The stock has a market cap of $12.02 billion, a P/E ratio of 13.99, a PEG ratio of 1.07 and a beta of 0.99. DaVita Inc. has a 1-year low of $125.64 and a 1-year high of $179.60.

DaVita (NYSE:DVA) last issued its quarterly earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. On average, research analysts expect that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research analysts recently weighed in on the company. StockNews.com lowered DaVita from a “buy” rating to a “hold” rating in a research report on Friday, March 21st. Barclays lifted their target price on shares of DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a report on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 price target on DaVita in a report on Friday, February 21st. Finally, Cowen restated a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, DaVita has an average rating of “Hold” and an average target price of $166.33.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.